Royal Bank of Canada
RY
The Toronto-Dominion Bank
TD
Bank of Nova Scotia
BNS
4
Bank of Montreal
BMO
5
Canadian Imperial Bank of Commerce
CM
CA Stock MarketDetailed Quotes
NRX NurExone Biologic Inc
- 0.600
- +0.020+3.45%
15min DelayMarket Closed Jan 23 16:00 ET
42.54MMarket Cap-6.32P/E (TTM)
0.600High0.580Low26.97KVolume0.580Open0.580Pre Close15.78KTurnover1.19052wk High0.04%Turnover Ratio70.89MShares0.27052wk Low-0.095EPS TTM39.70MFloat Cap1.190Historical HighLossP/E (Static)66.17MShs Float0.100Historical Low-0.107EPS LYR3.45%Amplitude--Dividend TTM10.17P/B1Lot Size--Div YieldTTM
NurExone Biologic Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 10.40%1.29M | 24.53%1.32M | 27.96%920K | -34.00%3.66M | -14.86%716K | 17.81%1.16M | -28.57%1.06M | -67.73%719K | 223.47%5.54M | -6.97%841K |
| Selling and administrative expenses | 2.62%782K | 34.66%812K | 101.45%695K | -49.35%2.1M | -12.67%386K | 34.63%762K | -48.94%603K | -82.28%345K | 262.81%4.14M | -27.18%442K |
| -General and administrative expense | 2.62%782K | 34.66%812K | 101.45%695K | -49.35%2.1M | -12.67%386K | 34.63%762K | -48.94%603K | -82.28%345K | 262.81%4.14M | -27.18%442K |
| Research and development costs | 25.12%503K | 11.16%508K | -39.84%225K | 10.78%1.54M | -19.74%309K | -4.74%402K | 50.83%457K | 33.10%374K | 142.76%1.39M | 29.63%385K |
| Depreciation amortization depletion | ---- | ---- | ---- | 50.00%21K | ---- | ---- | ---- | ---- | --14K | ---- |
| -Depreciation and amortization | ---- | ---- | ---- | 50.00%21K | ---- | ---- | ---- | ---- | --14K | ---- |
| Operating profit | -10.40%-1.29M | -24.53%-1.32M | -27.96%-920K | 34.00%-3.66M | 14.86%-716K | -17.81%-1.16M | 28.57%-1.06M | 67.73%-719K | -223.47%-5.54M | 6.97%-841K |
| Net non-operating interest income (expenses) | 483.33%35K | -125.00%-5K | -114.29%-2K | 333.33%42K | -99.16%3K | 142.86%6K | 107.25%20K | 116.09%14K | -38.46%-18K | 548.75%359K |
| Non-operating interest income | 516.67%37K | -38.46%16K | ---- | ---- | ---- | --6K | --26K | ---- | ---- | ---- |
| Non-operating interest expense | --2K | 250.00%21K | ---- | -90.91%3K | ---3K | --0 | --6K | ---- | 175.00%33K | ---- |
| Total other finance cost | ---- | ---- | 114.29%2K | -200.00%-45K | ---- | ---- | ---- | -116.09%-14K | -1,600.00%-15K | -676.47%-392K |
| Other net income (expenses) | 99.08%-24K | -3,403.80%-2.61M | -532K | |||||||
| Gain on sale of security | ---- | ---- | ---- | 99.57%-2K | ---- | ---- | ---- | ---- | -689.87%-466K | ---- |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---2.08M | --0 |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --2.08M | --0 |
| Other non-operating income (expenses) | ---- | ---- | ---- | 66.67%-22K | ---- | ---- | ---- | ---- | ---66K | ---- |
| Income before tax | -7.94%-1.25M | -27.40%-1.33M | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -7.94%-1.25M | -27.40%-1.33M | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M |
| Net income continuous operations | -7.94%-1.25M | -27.40%-1.33M | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -7.94%-1.25M | -27.40%-1.33M | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -7.94%-1.25M | -27.40%-1.33M | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M |
| Diluted earnings per share | 23.08%-0.02 | 8.33%-0.022 | 0.00%-0.016 | 62.50%-0.081 | 0.00%-0.015 | 13.33%-0.026 | 79.31%-0.024 | 70.71%-0.016 | -455.86%-0.216 | 29.75%-0.015 |
| Basic earnings per share | 23.08%-0.02 | 8.33%-0.022 | 0.00%-0.016 | 62.50%-0.081 | 0.00%-0.015 | 13.33%-0.026 | 79.31%-0.024 | 70.71%-0.016 | -455.86%-0.216 | 29.75%-0.015 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending Stocks
Big Five Big Five
The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.
Unlock Now